342 related articles for article (PubMed ID: 25889059)
1. The translational potential of circulating tumour DNA in oncology.
Patel KM; Tsui DW
Clin Biochem; 2015 Oct; 48(15):957-61. PubMed ID: 25889059
[TBL] [Abstract][Full Text] [Related]
2. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
[TBL] [Abstract][Full Text] [Related]
3. Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq.
Bratman SV; Newman AM; Alizadeh AA; Diehn M
Expert Rev Mol Diagn; 2015 Jun; 15(6):715-9. PubMed ID: 25773944
[TBL] [Abstract][Full Text] [Related]
4. Molecular Tumor Boards in Clinical Practice.
Luchini C; Lawlor RT; Milella M; Scarpa A
Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
[TBL] [Abstract][Full Text] [Related]
5. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.
Gašperšič J; Videtič Paska A
Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122
[TBL] [Abstract][Full Text] [Related]
6. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.
Postel M; Roosen A; Laurent-Puig P; Taly V; Wang-Renault SF
Expert Rev Mol Diagn; 2018 Jan; 18(1):7-17. PubMed ID: 29115895
[TBL] [Abstract][Full Text] [Related]
7. [Precision Oncology: Approaching the Target].
Hiddemann W
Dtsch Med Wochenschr; 2017 Nov; 142(22):1637. PubMed ID: 29078208
[No Abstract] [Full Text] [Related]
8. Circulating tumor DNA-From bench to bedside.
Lim JSJ; Janku F; Yap TA
Curr Probl Cancer; 2017; 41(3):212-221. PubMed ID: 28416241
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
10. [Precision medicine from experimental to clinical applications in oncology].
Normanno N
Recenti Prog Med; 2015 Dec; 106(12):597-600. PubMed ID: 26780068
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Wan JCM; Massie C; Garcia-Corbacho J; Mouliere F; Brenton JD; Caldas C; Pacey S; Baird R; Rosenfeld N
Nat Rev Cancer; 2017 Apr; 17(4):223-238. PubMed ID: 28233803
[TBL] [Abstract][Full Text] [Related]
12. Cell-free DNA diagnostics: current and emerging applications in oncology.
Muluhngwi P; Valdes R; Fernandez-Botran R; Burton E; Williams B; Linder MW
Pharmacogenomics; 2019 Apr; 20(5):357-380. PubMed ID: 30983510
[TBL] [Abstract][Full Text] [Related]
13. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
Cabel L; Proudhon C; Mariani P; Tzanis D; Beinse G; Bieche I; Pierga JY; Bidard FC
Eur J Surg Oncol; 2017 May; 43(5):949-962. PubMed ID: 28185687
[TBL] [Abstract][Full Text] [Related]
15. Use of cell free DNA in breast oncology.
Canzoniero JV; Park BH
Biochim Biophys Acta; 2016 Apr; 1865(2):266-74. PubMed ID: 27012505
[TBL] [Abstract][Full Text] [Related]
16. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G; Aftimos P; Awada A
Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
[TBL] [Abstract][Full Text] [Related]
17. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
Ponti G; Manfredini M; Tomasi A
Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
[TBL] [Abstract][Full Text] [Related]
18. Circulating Cell-Free DNA-Diagnostic and Prognostic Applications in Personalized Cancer Therapy.
Oellerich M; Schütz E; Beck J; Walson PD
Ther Drug Monit; 2019 Apr; 41(2):115-120. PubMed ID: 30883505
[TBL] [Abstract][Full Text] [Related]
19. Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.
Roschewski M; Staudt LM; Wilson WH
Blood; 2016 Jun; 127(25):3127-32. PubMed ID: 27081097
[TBL] [Abstract][Full Text] [Related]
20. Computational optimisation of targeted DNA sequencing for cancer detection.
Martinez P; McGranahan N; Birkbak NJ; Gerlinger M; Swanton C
Sci Rep; 2013 Dec; 3():3309. PubMed ID: 24296834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
